Real-time enrollment status for this myasthenia gravis clinical trial
Current Status
Recruiting
Checked: July 17, 2026 at 1:11 PM UTC
| NCT Number | NCT06799247 |
| Recruiting Status | Recruiting |
| Condition | Myasthenia Gravis |
| Phase | PHASE3 |
| Target Enrollment | 100 participants |
| Active Locations | 23 sites in the US |
| Sponsor | Cartesian Therapeutics |
| Last Updated on CT.gov | March 24, 2026 (Mar 24, 2026) |
As of July 17, 2026: Clinical trial NCT06799247 is currently recruiting participants. This phase3 study for myasthenia gravis is actively seeking new participants at 23 locations across the United States. The study is sponsored by Cartesian Therapeutics. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06799247 is actively recruiting participants as of July 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 23 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06799247 was last updated Mar 24, 2026 (March 24, 2026). HelloStudys verifies this status automatically.